{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T08:02:17Z","timestamp":1769068937903,"version":"3.49.0"},"publisher-location":"Chichester, UK","reference-count":24,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd001927","type":"reference-entry","created":{"date-parts":[[2003,11,21]],"date-time":"2003-11-21T03:33:39Z","timestamp":1069385619000},"source":"Crossref","is-referenced-by-count":9,"title":["Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks"],"prefix":"10.1002","author":[{"given":"O","family":"Benavente","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Hart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Koudstaal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Laupacis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"McBride","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[1999,10,25]]},"reference":[{"key":"10.1002\/14651858.CD001927-BIB1|cit1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0140-6736(89)91200-2","article-title":"Placebo-controlled, randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: the Copenhagen AFASAK study","volume":"1","author":"Petersen","year":"1989","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001927-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1056\/NEJM199011293232201","article-title":"The effect of low-dose warfarin on the risk of stroke in nonrheumatic atrial fibrillation","volume":"323","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1002\/14651858.CD001927-BIB3|cit3","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0735-1097(91)90585-W","article-title":"Canadian Atrial Fibrillation Anticoagulation (CAFA) Study","volume":"18","year":"1991","journal-title":"J Am Coll Cardiol"},{"key":"10.1002\/14651858.CD001927-BIB4|cit4","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1161\/01.CIR.84.2.527","article-title":"The Stroke Prevention in Atrial Fibrillation Study: Final results","volume":"84","year":"1991","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD001927-BIB5|cit5","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJM199211123272002","article-title":"Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation","volume":"327","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1002\/14651858.CD001927-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1001\/archinte.158.14.1513","article-title":"Mini-dose warfarin and aspirin in atrial fibrillation. Second Copenhagen Atrial Fibrillation, Aspirin and Anticoagulation Study (AFASAK 2)","volume":"158","author":"Gullov","year":"1998","journal-title":"Arch Int Med"},{"key":"10.1002\/14651858.CD001927-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/0140-6736(93)92358-Z","article-title":"Secondary prevention of vascular events in patients with nonrheumatic atrial fibrillation and recent transient ischemic attack or minor ischemic stroke","volume":"342","year":"1993","journal-title":"Lancet"},{"issue":"suppl","key":"10.1002\/14651858.CD001927-BIB8|cit8","first-page":"116","article-title":"Prophylaxis of embolic events in patients with atrial fibrillation using low molecular weight heparin","volume":"19","author":"Harenberg","year":"1993","journal-title":"Semin Thromb Hemostasis"},{"issue":"suppl 4","key":"10.1002\/14651858.CD001927-BIB9|cit9","first-page":"11","article-title":"Primary Prevention of arterial thromboembolism in patients with nonrheumatic atrial fibrillation in general practice (the PATAF study)","volume":"7","author":"Hellemons","year":"1997","journal-title":"Cerebrovas Dis"},{"key":"10.1002\/14651858.CD001927-BIB10|cit10","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0002-9149(98)00357-9","article-title":"Effectiveness of fixed mindose warfarin in the prevention of thromboembolism and vascular death in nonrheumatic atrial fibrillation","volume":"82","author":"Pengo","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1002\/14651858.CD001927-BIB11|cit11","first-page":"687","article-title":"Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation. Stroke Prevention in Atrial Fibrillation II Study","volume":"343","year":"1994","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001927-BIB12|cit12","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0140-6736(96)03487-3","article-title":"Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: The Stroke Prevention in Atrial Fibrillation III randomized clinical trial","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001927-BIB13|cit13","first-page":"1949","article-title":"Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: Analysis of pooled data from five randomized clinical trials","volume":"154","year":"1994","journal-title":"Arch Intern Med"},{"key":"10.1002\/14651858.CD001927-BIB14|cit14","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1001\/archinte.1995.00430050045005","article-title":"Prevalence, age distribution, and gender of patients with atrial fibrillation","volume":"155","author":"Feinberg","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.1002\/14651858.CD001927-BIB15|cit15","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1212\/WNL.51.3.674","article-title":"Prevention of stroke in patients with nonvalvular atrial fibrillation","volume":"51","author":"Hart","year":"1998","journal-title":"Neurology"},{"issue":"6","key":"10.1002\/14651858.CD001927-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1161\/01.STR.30.6.1223","article-title":"Factors associated with ischemic stroke during apsirin therapy in atrial fibrillation: Analysis of 2012 participants in the SPAF I-III clinical trials","volume":"30","author":"Hart","year":"1999","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD001927-BIB17|cit17","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM198709103171104","article-title":"The natural history of lone atrial fibrillation: A population-based study over three decades","volume":"317","author":"Kopecky","year":"1987","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1002\/14651858.CD001927-BIB18|cit18","article-title":"Anticoagulants for preventing stroke in patients with nonrheumatic atrial fibrillation and history of stroke or transient ischemic attacks (Cochrane Review)","author":"Koudstaal","year":"1999","journal-title":"The Cochrane Library"},{"issue":"suppl","key":"10.1002\/14651858.CD001927-BIB19|cit19","doi-asserted-by":"crossref","first-page":"579S","DOI":"10.1378\/chest.114.5_Supplement.579S","article-title":"Antithrombotic therapy in atrial fibrillation","volume":"114","author":"Laupacis","year":"1998","journal-title":"Chest"},{"key":"10.1002\/14651858.CD001927-BIB20|cit20","first-page":"15","article-title":"Predictors of thromboembolism in atrial fibrillation I: Clinical features in patients at risk","volume":"116","year":"1992","journal-title":"Ann Int Med"},{"key":"10.1002\/14651858.CD001927-BIB21|cit21","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1052-3057(10)80166-1","article-title":"Risk factors for thromboembolism during aspirin therapy in atrial fibrillation","volume":"5","year":"1995","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1002\/14651858.CD001927-BIB22|cit22","first-page":"411","article-title":"Bleeding during antithrombotic therapy for atrial fibrillation","volume":"156","year":"1996","journal-title":"Arch Int Med"},{"key":"10.1002\/14651858.CD001927-BIB23|cit23","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1001\/jama.279.16.1273","article-title":"Prospective identification of patients with nonvalvular atrial fibrillation at low-risk of stroke during treatment with aspirin","volume":"279","year":"1998","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD001927-BIB24|cit24","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","article-title":"Atrial fibrillation as an independent risk factor for stroke: The Framingham Study","volume":"22","author":"Wolf","year":"1991","journal-title":"Stroke"}],"updated-by":[{"DOI":"10.1002\/14651858.cd001927.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2005,7,20]],"date-time":"2005-07-20T00:00:00Z","timestamp":1121817600000}}],"container-title":["The Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD001927","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T21:07:13Z","timestamp":1628543233000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD001927"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,10,25]]},"references-count":24,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd001927","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD001927.pub2","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[1999,10,25]]}}}